Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-10-14 Purchase | 2026-10-14 6:58 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 10,040 | $84.56 | $848,977 | 224,865 (Indirect) | View |
| 2026-09-25 Purchase | 2026-09-28 5:47 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 10,000 | $99.88 | $998,784 | 960,413 (Indirect) | View |
| 2026-09-23 Purchase | 2026-09-23 4:59 pm | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 5,000 | $100 | $500,000 | 1,074,046 (Indirect) | View |
| 2026-09-16 Purchase | 2026-09-17 5:46 pm | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 5,000 | $100 | $500,000 | 1,069,046 (Indirect) | View |
| 2026-09-11 Sale | 2026-09-15 5:52 pm | Inhibrx Biosciences Inc. | INBX | MANHARD KIMBERLY Director | 1,500 | $109.03 | $163,543 | 7,500 (Indirect) | View |
| 2026-09-08 Sale | 2026-09-10 7:06 pm | Inhibrx Biosciences Inc. | INBX | MANHARD KIMBERLY Director | 1,000 | $115.47 | $115,468 | 9,000 (Indirect) | View |
| 2026-09-08 Purchase | 2026-09-08 5:23 pm | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 5,000 | $113.52 | $567,580 | 1,064,046 (Indirect) | View |
| 2026-09-08 Purchase | 2026-09-08 4:26 pm | Inhibrx Biosciences Inc. | INBX | FORSYTH DOUGLAS Director | 2,500 | $114.65 | $286,617 | 227,064 (Indirect) | View |
| 2026-09-08 Purchase | 2026-09-08 4:04 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 25,000 | $105.82 | $2,645,399 | 950,413 (Indirect) | View |
| 2025-10-07 Sale | 2025-10-09 4:41 pm | Inhibrx Biosciences Inc. | INBX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 350,000 | $32.25 | $11,287,500 | 102,864 (Indirect) | View |
| 2024-11-19 Purchase | 2024-11-22 4:03 pm | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 107,186 | $14.21 | $1,523,620 | 69,843 (Indirect) | View |
| 2024-10-03 Purchase | 2024-10-07 4:34 pm | Inhibrx Biosciences Inc. | INBX | Vuori Kristiina MD Director | 6,667 | $15 | $100,005 | 20,443 (Direct) | View |
| 2024-09-12 Purchase | 2024-09-16 5:12 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 40,000 | $15.73 | $629,117 | 925,413 (Indirect) | View |
| 2024-09-10 Purchase | 2024-09-12 5:14 pm | Inhibrx Biosciences Inc. | INBX | Vuori Kristiina MD Director | 6,636 | $15.07 | $99,992 | 13,776 (Direct) | View |
| 2024-09-06 Purchase | 2024-09-10 5:00 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 44,000 | $15.25 | $671,150 | 885,413 (Indirect) | View |
| 2024-08-29 Purchase | 2024-09-03 5:31 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 40,000 | $14.92 | $596,763 | 841,413 (Indirect) | View |
| 2024-08-29 Purchase | 2024-09-03 4:27 pm | Inhibrx Biosciences Inc. | INBX | Vuori Kristiina MD Director | 7,140 | $14 | $99,960 | 7,140 (Direct) | View |
| 2024-08-28 Purchase | 2024-08-30 4:16 pm | Inhibrx Biosciences Inc. | INBX | MANHARD KIMBERLY Director | 10,000 | $13.98 | $139,800 | 10,000 (Indirect) | View |
| 2024-08-22 Purchase | 2024-08-26 4:26 pm | Inhibrx Biosciences Inc. | INBX | FORSYTH DOUGLAS Director | 75,000 | $13.83 | $1,037,328 | 224,564 (Indirect) | View |
| 2024-08-20 Purchase | 2024-08-22 4:29 pm | Inhibrx Biosciences Inc. | INBX | Lappe Mark Chief Executive Officer | 40,000 | $12.96 | $518,282 | 801,413 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-03 Option Award(A) | 2026-09-18 4:26 pm | 2027-06-03 2036-06-03 | Inhibrx Biosciences Inc. | INBX | FORSYTH DOUGLAS Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2026-06-03 Option Award(A) | 2026-09-18 4:25 pm | 2027-06-03 2036-06-03 | Inhibrx Biosciences Inc. | INBX | Vuori Kristiina MD Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2026-06-03 Option Award(A) | 2026-09-18 4:22 pm | 2027-06-03 2036-06-03 | Inhibrx Biosciences Inc. | INBX | MANHARD KIMBERLY Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2026-06-03 Option Award(A) | 2026-09-18 4:20 pm | 2027-06-03 2036-06-03 | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-04 5:29 pm | 2027-06-03 2036-06-03 | Inhibrx Biosciences Inc. | INBX | Vuori Kristiina MD Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-04 5:29 pm | 2027-06-03 2036-06-03 | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-04 5:28 pm | 2027-06-03 2036-06-03 | Inhibrx Biosciences Inc. | INBX | FORSYTH DOUGLAS Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2026-06-03 Option Award | 2026-06-04 5:28 pm | 2027-06-03 2036-06-03 | Inhibrx Biosciences Inc. | INBX | MANHARD KIMBERLY Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2026-04-24 Option Award | 2026-04-27 4:48 pm | N/A 2036-04-24 | Inhibrx Biosciences Inc. | INBX | Matly David President | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:35 pm | 2026-05-28 2035-05-28 | Inhibrx Biosciences Inc. | INBX | MANHARD KIMBERLY Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:32 pm | 2026-05-28 2035-05-28 | Inhibrx Biosciences Inc. | INBX | Vuori Kristiina MD Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:27 pm | 2026-05-28 2035-05-28 | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:24 pm | 2026-05-28 2035-05-28 | Inhibrx Biosciences Inc. | INBX | FORSYTH DOUGLAS Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-02 4:39 pm | N/A 2035-04-01 | Inhibrx Biosciences Inc. | INBX | Deck Kelly Chief Financial Officer | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-02 4:34 pm | N/A 2035-04-01 | Inhibrx Biosciences Inc. | INBX | Matly David President | 50,000 | $0 | 50,000 (Direct) | View |
Ownership | 2025-04-02 4:31 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INBX | Matly David President | 0 | $0 | 175,000 (Direct) | View |
| 2025-03-27 Gift | 2025-03-28 5:37 pm | N/A N/A | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 90,000 | $0 | 1,059,046 (Indirect) | View |
| 2024-12-16 Gift | 2024-12-17 4:29 pm | N/A N/A | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 750,000 | $0 | 389,686 (Indirect) | View |
| 2024-12-06 Gift | 2024-12-06 4:51 pm | N/A N/A | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 52,000 | $0 | 1,149,046 (Indirect) | View |
| 2024-06-24 Gift | 2024-06-24 5:27 pm | N/A N/A | Inhibrx Biosciences Inc. | INBX | Kayyem Jon Faiz Director | 99,050 | $0 | 16,250 (Indirect) | View |